Evommune, Inc.
EVMN
$18.87
-$0.02-0.11%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -12.48M | -13.57M | -14.56M | -15.92M | |
| Total Depreciation and Amortization | 311.00K | 375.00K | 377.00K | 331.00K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 49.00K | -8.75M | 244.00K | 77.00K | |
| Change in Net Operating Assets | 2.48M | -4.27M | -9.96M | -10.72M | |
| Cash from Operations | -9.64M | -26.21M | -23.90M | -26.23M | |
| Capital Expenditure | -131.00K | -- | -- | 0.00 | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -23.78M | 18.00M | 13.50M | 9.41M | |
| Cash from Investing | -23.91M | 18.00M | 13.50M | 9.41M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -136.00K | -155.00K | -154.00K | -114.00K | |
| Issuance of Common Stock | 0.00 | 4.00K | 2.00K | 0.00 | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | 0.00 | 65.23M | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -138.00K | -736.00K | -- | -- | |
| Cash from Financing | -274.00K | 64.34M | -152.00K | -114.00K | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -33.82M | 56.13M | -10.55M | -16.93M | |